Advances in the Diagnosis and Treat

Advances in the Diagnosis and Treatment of Enthesitis-Related ArthritisAdvances in the treatment of polyarticular juvenile idiopathic arthritisAt the horizon of innovative therapy in rheumatology: new biologic agentsBaricitinib in juvenile idiopathic arthritis: an international, phase 3, randomised, double-blind, placebo-controlled, withdrawal, efficacy, and safety trialBeneficial Effect of Upadacitinib in an Adult Patient with Juvenile Idiopathic Arthritis-associated Uveitis after Unsatisfactory Response to Tofacitinib: A Case ReportBeyond the guidelines management of juvenile idiopathic arthritis: a case report of a girl with polyarticular disease refractory to multiple treatment options and Leri Weill syndromeBiologic disease modifying antirheumatic drugs and Janus kinase inhibitors in paediatric rheumatology - what we know and what we do not know from randomized controlled trialsBiological and Clinical Changes in a Pediatric Series Treated with Off-Label JAK InhibitorsBiologics for the treatment of noninfectious uveitis: current concepts and emerging therapeuticsBiologics in Pediatric Rheumatology: Quo Vadis?Clinical effectiveness and safety of baricitinib for the treatment of juvenile idiopathic arthritis-associated uveitis or chronic anterior antinuclear antibody-positive uveitis: study protocol for an open-label, adalimumab active-controlled phase 3 clinical trial (JUVE-BRIGHT)Coatomer-associated protein subunit alpha syndrome: abnormal trafficking between the Golgi complex and the endoplasmic reticulumConnective tissue disease with macrophage activation syndrome: A case reportCorrection to: Interfering with interferons: targeting the JAK-STAT pathway in complications of systemic juvenile idiopathic arthritis (SJIA)